OpenAIRE is about to release its new face with lots of new content and services.
During September, you may notice downtime in services, while some functionalities (e.g. user registration, login, validation, claiming) will be temporarily disabled.
We apologize for the inconvenience, please stay tuned!
For further information please contact helpdesk[at]openaire.eu

fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Rizi, K; Green, Rebecca J.; Donaldson, M. X.; Williams, Adrian C. (2011)
Publisher: Springer Verlag
Languages: English
Types: Article
Subjects:
Abstract\ud Purpose: The pH discrepancy between healthy and atopic dermatitis skin was identified as a site specific trigger for delivering hydrocortisone from microcapsules. \ud Methods: Using Eudragit L100, a pH-responsive polymer which dissolves at pH 6, hydrocortisone-loaded microparticles were produced by oil-in-oil microencapsulation or spray drying. Release and permeation of hydrocortisone from microparticles alone or in gels was assessed and preliminary stability data was determined.\ud Results: Drug release from microparticles was pH-dependent though the particles produced by spray drying also gave significant non-pH dependent burst release, resulting from their porous nature or from drug enrichment on the surface of these particles. This pH-responsive release was maintained upon incorporation of the oil-in-oil microparticles into Carbopol- and HPMC-based gel formulations. In-vitro studies showed 4 to 5-fold higher drug permeation through porcine skin from the gels at pH 7 compared to pH 5. \ud Conclusions: Permeation studies showed that the oil-in-oil generated particles deliver essentially no drug at normal (intact) skin pH (5.0 – 5.5) but that delivery can be triggered and targeted to atopic dermatitis skin where the pH is elevated. The incorporation of these microparticles into Carbopol- and HPMC-based aqueous gel formulations demonstrated good stability and pH-responsive permeation into porcine skin.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1.
    • 2. Ohman EM, Rogers S, Meenan FO, McKenna TJ. Adrenal suppression following low-dose topical clobetasol propionate. J R Soc Med. 1987;80(7):422-4.
    • 3. Schäcke H, Schottelius A, Döcke W-D, Strehlke P, Jaroch S, Schmees N, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. PNAS. 2004;101(1):227- 32.
    • 4. Fluhr JW, Elias PM. Stratum corneum pH: formation and function of the "acid mantle". Exogenous Dermatol. 2002;1:163-75.
    • 5. Eberlein-König B, Schafer T, Huss-Marp J, Darsow U, Mohrenschlager M, Herbert O, et al. Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol. 2000;80:188-91.
    • 6. Schmid-Wendtner MH, Korting HC. The pH of the Skin Surface and Its Impact on the Barrier Function. Skin Pharmacol Physiol. 2006;19(6):296-302.
    • 7. Sparavigna A, Setaro M, Gualandri V. Cutaneous pH in children affected by atopic dermatitis and in healthy children: a multicenter study. Skin Res Technol. 1999;5(4):221-7.
    • 8. Chikakane K, Takahashi H. Measurement of skin pH and its significance in cutaneous diseases. Clin Dermatol. 1995 1995/8//;13(4):299-306.
    • 9. Anderson D. The acid-base balance of the skin. Br J Dermatol. 1951;63:283-96.
    • 10. Rizi K, Green RJ, Khutoryanskaya O, Donaldson M, Williams AC. Mechanisms of burst release from pH-responsive polymeric microparticles. J Pharm. Pharmacol., 2010:In Press.
    • 11. Rizi K, Green RJ, Donaldson M, Williams AC. Production of pH-responsive microparticles by spray drying: Investigation of experimental parameter effects on morphological and release properties. J Pharm Sci. 2010;100(2):566-79.
    • 12. Kendall RA, Alhnan MA, Nilkumhang S, Murdan S, Basit AW. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery. Eur J Pharm Sci. 2009;37(3-4):284-90.
    • 13. Jacobi, U., Kaiser, M., Toll, R., Mangelsdorf, S., Audring, H., Otberg, N., Sterry, W., Lademann, J.,2007.Porcine ear skin: an in vitro model for human skin. Skin Res and Tech, 13, 19-24.
    • 14. Muhammad, F., Brooks, J. D., Riviere, J. E.,2004.Comparative mixture effects of JP(100) additives on the dermal absorption and disposition of jet fuel hydrocarbons in different membrane model systems. Toxicology Letters, 150, 351-365.
    • 15. French DL, Himmelstein KJ, Mauger JW. Physicochemical aspects of controlled release of substituted benzoic and naphthoic acids from Carbopol® gels. J Controlled Release. 1995;37(3):281-9.
    • 16. Salama R, Hoe S, Chan H-K, Traini D, Young PM. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 1: Influence of polymer concentration on physical and in vitro characteristics. Eur J Pharm Biopharm. 2008;69(2):486-95.
    • 17. Klee SK, Farwick M, Lersch P. Triggered release of sensitive active ingredients upon response to the skin's natural pH. Colloids Surf Physicochem Eng Aspects. 2009;338(1- 3):162-6.
    • 18. Alvarez-Roman R, Barre G, Guy RH, Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm. 2001;52:191-5.
    • 19. Jenning V, Gysler A, Schafer-Korting M, Gohla S. Vitamin A loaded solid lipid nanoparticles for topical use:occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000;49:211-8.
    • 20. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Controlled Release. 2004;99(1):53.
    • 21. Zhao Y, Brown MB, Jones SA. Pharmaceutical foams: are they the answer to the dilemma of topical nanoparticles? Nanomed Nanotechnol Biol Med. 2010;6(2):227-36.
    • 22. Knorr F, Lademann J, Patzelt A, Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route - Research progress and future perspectives. Eur J Pharm Biopharm. 2008;71(2):173-80.
    • 23. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles - An efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66(2):159.
    • 24. Flynn GL. Comparision between in vivo techniques. Acta Pharm Suce. 1983;20:54-9.
    • 25. Poulsen BJ, Flynn GL. In vitro methods to study dermal delivery and percutaneous absorption. In: Bronaugh RL, Maibach HI, editors. Percutaneous absorption: Mechanism, absorption and drug delivery. New York: Marcel Dekker; 1985. p. 431-59.
    • 26. Salama RO, Traini D, Chan H-K, Young PM. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm. 2008;70(1):145-52.
    • 27. British National Formulary. 59 ed: British Medical Association & Royal Pharmaceutical Society of Great Britain; March 2010.
    • 28. Barry BW. Dermatological formulations:percutaneous absorption. 1st ed. New York: Marcel Dekker Inc; 1993.
    • 29. Stankler L. Diseases of the skin. Br Med J. 1974;1:27-9.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok